Education
About Us
Working with TipRanks
Follow Us
Revance Therapeutics (RVNC)
NASDAQ:RVNC
RESEARCH TOOLSreports
The following ETFs maintain exposure to Revance Therapeutics (RVNC). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
40 ETFs Hold Revance Therapeutics (RVNC)
Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in RVNC |
|---|---|---|---|---|---|---|
| ProShares Merger ETF | $10.47M | 0.75% | 1.18% | $134.74K | 0.04% | |
| Invesco NASDAQ Future Gen 200 ETF | $7.51M | 0.20% | 0.48% | $41.60K | 0.01% | |
| IQ Merger Arbitrage ETF | $231.68M | 0.77% | 0.44% | $943.66K | 0.27% | |
| Inspire Small/Mid Cap Impact ETF | $184.81M | 0.57% | 0.22% | $417.74K | 0.12% | |
| iShares U.S. Pharmaceuticals ETF | $549.83M | 0.39% | 0.11% | $673.68K | 0.20% | |
| iShares Micro-Cap ETF | $772.99M | 0.60% | 0.09% | $794.51K | 0.23% | |
| iShares NASDAQ US Biotechnology UCITS ETF | $23.56M | 0.35% | 0.04% | $177.25K | 0.05% | |
| Fidelity Global Equity+ Fund Trust Units | $137.05M | 0.00% | 0.04% | $1.51M | 0.29% | |
| Invesco Nasdaq Biotechnology ETF | $34.97M | 0.19% | 0.03% | $12.95K | <0.01% | |
| iShares Biotechnology ETF | $5.17B | 0.45% | 0.03% | $2.01M | 0.58% |
